Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3 without changing the study content shown in the record.
    Difference
    0.1%
    Check dated 2026-04-24T06:15:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:23.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T23:01:17.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:04:16.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2. The funding-status notice has been removed (the previous Revision: v3.4.1 was deleted).
    Difference
    0.5%
    Check dated 2026-02-11T09:25:11.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a funding-status notice at the top of the page about potential data currency issues and a Revision banner showing v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:17:59.000Z thumbnail image

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.